hotspot -WSS

hotspot

author：focus 2025-08-23 21:58:22 - browse：141

Susan Tousi is leaving Illumina to become CEO of cancer liquid-biopsy startup Delfi. Nasdaq

Delfi Diagnostics, a startup devising new ways to use routine blood draws to detect early signs of cancer, told STAT Thursday that it has appointed Susan Tousi, chief commercial officer for genomics giant Illumina, as its new CEO. She is the fourth senior executive to leave Illumina since June.

Tousi will start next week, just in time for the J.P. Morgan Healthcare Conference, while founding CEO Victor Velculescu will remain on the company’s board to help guide its research programs. Tousi’s selection is part of a bid by Delfi to expand its commercial efforts and build on the initial launch of its lung cancer screening test last fall, the latest example of growing interest in the vast and increasingly competitive liquid biopsy market.

Illumina’s own ambitions to enter this space recently came undone after a prolonged battle with U.S. and European regulators finally pushed the company to announce last month that it would divest Grail, which it had acquired for $8 billion two years earlier. Bas Verhoef, Illumina’s head of region for Europe, will serve as interim chief commercial officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： When women are denied an abortion, their children fare worse than peers

WSS

Young boy dies in trial for Pfizer Duchenne gene therapy

Medicare Advantage 2025 payments will dip, Biden administration says

Bill would stop addiction treatment from triggering child abuse inquiry

Republican states more likely to report Covid vaccine side effects

Stroke deaths set to near 10 million globally by 2050

Colorectal cancer study finds potential in overlooked immune cell

Wikipedia

hotspot

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Covid silver lining: Unprecedented look at human immune system

Psychedelics group wrestles with new pharma identity

Study: Black kids more likely to die after surgery than white kids

Psychedelics group wrestles with new pharma identity

Republican states more likely to report Covid vaccine side effects

Novavax promises a turnaround & Lilly roils the obesity market

First Opinion on colorectal cancer screening: letter and response

Sports medicine is finally prioritizing gender equality

Sana to lay off nearly a third of staff, de

Wikipedia

3 questions for the future of Biden's cancer moonshot

Oral obesity drug from Viking Therapeutics hits key early target

FDA authorizes Novavax’s updated Covid

Florida Supreme Court upholds state's abortion ban

First Opinion on colorectal cancer screening: letter and response

Mass General Brigham physicians react to latest merger step

explore

explore

focus

explore